Bleeding Disorders
News
Lentiviral gene therapy could prove useful for adults with hemophilia
News
JAK inhibitor more effective than standard therapy for polycythemia vera
Key clinical point: Ruxolitinib, now approved for treatment of polycythemia vera in the United States, is an alternative to hydroxyurea in...
News
FDA expands ruxolitinib approval to include polycythemia vera
Clinical Review
Management of Bleeding Complications in Patients with Cancer
News
Drug gets orphan status for PNH in US
The US Food and Drug Administration (FDA) has granted the complement inhibitor AMY-101 orphan status as a treatment for paroxysmal nocturnal...
News
Drug granted orphan status for PNH in EU
A novel compound has received orphan status in the Europe Union to treat paroxysmal nocturnal hemoglobinuria (PNH), a life-threatening disease...
Conference Coverage
Thalidomide offers short-term efficacy in HHT
All 29 evaluable patients responded to thalidomide, with 4 achieving a complete response. Unfortunately, 11 patients relapsed at a median of 43...
Conference Coverage
Eltrombopag reduces bleeding in children with chronic immune thrombocytopenia
Key clinical point: Eltrombopag may soon be a treatment option for children with chronic immune thrombocytopenia. Major finding: Platelet response...
News
New approach for treating PNH
Investigators have identified a novel strategy for treating paroxysmal nocturnal hemoglobinuria (PNH), according to a paper published in Blood....
News
Platelets, iron may affect stroke risk in HHT patients
Credit: Andre E.X.